| Ident. | Authors (with country if any) | Title |
|---|
| 000081 (2003) |
Kanchan Anand [Allemagne] ; John Ziebuhr ; Parvesh Wadhwani ; Jeroen R. Mesters ; Rolf Hilgenfeld | Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. |
| 000147 (2003) |
Bin Xiong [République populaire de Chine] ; Chun-Shan Gui ; Xiao-Ying Xu ; Cheng Luo ; Jing Chen ; Hai-Bin Luo ; Li-Li Chen ; Guo-Wei Li ; Tao Sun ; Chang-Ying Yu ; Li-Duo Yue ; Wen-Hu Duan ; Jing-Kang Shen ; Lei Qin ; Tie-Liu Shi ; Yi-Xue Li ; Kai-Xian Chen ; Xiao-Min Luo ; Xu Shen ; Jian-Hua Shen ; Hua-Liang Jiang | A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening. |
| 000618 (2004) |
Jeffrey H. Toney [États-Unis] ; Sonia Navas-Martín ; Susan R. Weiss ; Andreas Koeller | Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design. |
| 001077 (2005) |
Yu-San Han [République populaire de Chine] ; Gu-Gang Chang ; Chiun-Gung Juo ; Hong-Jen Lee ; Shiou-Hwei Yeh ; John Tsu-An Hsu ; Xin Chen | Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition. |
| 001135 (2005) |
Haitao Yang [République populaire de Chine] ; Weiqing Xie ; Xiaoyu Xue ; Kailin Yang ; Jing Ma ; Wenxue Liang ; Qi Zhao ; Zhe Zhou ; Duanqing Pei ; John Ziebuhr ; Rolf Hilgenfeld ; Kwok Yung Yuen ; Luet Wong ; Guangxia Gao ; Saijuan Chen ; Zhu Chen ; Dawei Ma ; Mark Bartlam ; Zihe Rao | Design of wide-spectrum inhibitors targeting coronavirus main proteases. |
| 001541 (2005) |
Qishi Du [République populaire de Chine] ; Shuqing Wang ; Zhiqin Jiang ; Weina Gao ; Yun Li ; Dongqing Wei ; Kuo-Chen Chou | Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides. |
| 001A10 (2007) |
D H Goetz [États-Unis] ; Y. Choe ; E. Hansell ; Y T Chen ; M. Mcdowell ; C B Jonsson ; W R Roush ; J. Mckerrow ; C S Craik | Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus. |
| 001A85 (2008) |
Chunying Niu [Canada] ; Jiang Yin ; Jianmin Zhang ; John C. Vederas ; Michael N G. James | Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro. |
| 001E27 (2009) |
Cheng-Chung Lee [Taïwan] ; Chih-Jung Kuo ; Tzu-Ping Ko ; Min-Feng Hsu ; Yao-Chen Tsui ; Shih-Cheng Chang ; Syaulan Yang ; Shu-Jen Chen ; Hua-Chien Chen ; Ming-Chu Hsu ; Shin-Ru Shih ; Po-Huang Liang ; Andrew H-J Wang | Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds. |
| 001E45 (2009) |
Krongsakda Phakthanakanok [Thaïlande] ; Khanok Ratanakhanokchai ; Khin Lay Kyu ; Pornthep Sompornpisut ; Aaron Watts ; Surapong Pinitglang | A computational analysis of SARS cysteine proteinase-octapeptide substrate interaction: implication for structure and active site binding mechanism. |
| 002109 (2010) |
Falgun Shah [États-Unis] ; Prasenjit Mukherjee ; Prashant Desai ; Mitchell Avery | Computational approaches for the discovery of cysteine protease inhibitors against malaria and SARS. |
| 002135 (2010) |
Parag P. Shah [États-Unis] ; Tianhua Wang ; Rachel L. Kaletsky ; Michael C. Myers ; Jeremy E. Purvis ; Huiyan Jing ; Donna M. Huryn ; Doron C. Greenbaum ; Amos B. Smith ; Paul Bates ; Scott L. Diamond | A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells. |
| 002485 (2012) |
Miyuki Kawase [Japon] ; Kazuya Shirato [Japon] ; Lia Van Der Hoek [Pays-Bas] ; Fumihiro Taguchi [Japon] ; Shutoku Matsuyama [Japon] | Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry |
| 002530 (2012) |
Martha Schneider [Allemagne] ; Kerstin Ackermann [Allemagne] ; Melissa Stuart [États-Unis] ; Claudia Wex [Allemagne] ; Ulrike Protzer [Allemagne] ; Hermann M. Sch Tzl [Allemagne, États-Unis] ; Sabine Gilch [Allemagne, États-Unis] | Severe Acute Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132 due to Proteasome-Independent Inhibition of M-Calpain |
| 002548 (2012) |
Ji-Young Park [Corée du Sud] ; Jang Hoon Kim ; Young Min Kim ; Hyung Jae Jeong ; Dae Wook Kim ; Ki Hun Park ; Hyung-Jun Kwon ; Su-Jin Park ; Woo Song Lee ; Young Bae Ryu | Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. |
| 002669 (2013) |
Ji-Young Park [Corée du Sud] ; Jang Hoon Kim ; Jung Min Kwon ; Hyung-Jun Kwon ; Hyung Jae Jeong ; Young Min Kim ; Doman Kim ; Woo Song Lee ; Young Bae Ryu | Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava. |
| 002689 (2013) |
Pillaiyar Thanigaimalai [Japon] ; Sho Konno [Japon] ; Takehito Yamamoto [Japon] ; Yuji Koiwai [Japon] ; Akihiro Taguchi [Japon] ; Kentaro Takayama [Japon] ; Fumika Yakushiji [Japon] ; Kenichi Akaji [Japon] ; Yoshiaki Kiso [Japon] ; Yuko Kawasaki [États-Unis] ; Shen-En Chen [États-Unis] ; Aurash Naser-Tavakolian [États-Unis] ; Arne Schön [États-Unis] ; Ernesto Freire [États-Unis] ; Yoshio Hayashi [Japon] | Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study |
| 002839 (2014) |
Yahira M. Báez-Santos [États-Unis] ; Scott J. Barraza ; Michael W. Wilson ; Michael P. Agius ; Anna M. Mielech ; Nicole M. Davis ; Susan C. Baker ; Scott D. Larsen ; Andrew D. Mesecar | X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases. |
| 002897 (2014) |
Yeong Hun Song ; Dae Wook Kim ; Marcus John Curtis-Long ; Heung Joo Yuk ; Yan Wang ; Ningning Zhuang ; Kon Ho Lee ; Kwon Seok Jeon ; Ki Hun Park | Papain-like protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits. |
| 002A03 (2015) |
Kai-Wen Cheng [Taïwan] ; Shu-Chun Cheng [Taïwan] ; Wei-Yi Chen [Taïwan] ; Min-Han Lin [Taïwan] ; Shang-Ju Chuang [Taïwan] ; I-Hsin Cheng [Taïwan] ; Chiao-Yin Sun [Taïwan] ; Chi-Yuan Chou [Taïwan] | Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus. |
| 002A07 (2014) |
Yahira M. Báez-Santos ; Sarah E. St. John ; Andrew D. Mesecar | The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds |
